Cancer Immunotherapy Helped With Good Gut Bacteria
Breakthrough to be assessed in new clinical trial
medpagetoday.com
Your gut bacteria could determine how you respond to cutting-edge cancer drugs
Planned trial will manipulate patients’ microbiomes
sciencemag.org
Tocilizumab looks promising for corticosteroid refractory anti-PD-1-related adverse events
CHICAGO – In a review of patients treated with nivolumab, 27 of 34 who were refractory to…
mdedge.com